Antibacterial Photodynamic Therapy in the Management of Peri-implantitis
Regular Home-use of Antibacterial Photodynamic Therapy in the Management of Peri-implantitis
Nilminie Rathnayake
80 participants
May 13, 2024
INTERVENTIONAL
Summary
This early-stage study is designed to determine the efficacy of the Lumoral method in periimplantitis. Improved supragingival plaque control can help to also sustain subgingival plaque management in the long term. In addition, the device might have a photobiomodulation effect on periodontal tissues, thus impacting osseointegration.
Eligibility
Inclusion Criteria4
- PPD ≥6 mm and marginal bone loss >3 mm
- Dental implants collected and clinically characterized according to Lähteenmäki et al. CEDR-22
- Agreement to participate in the study and to sign a written consent form
- Able to co-operate with the treatment protocol and avoid any other oral hygiene measures outside of the study protocol
Exclusion Criteria9
- Presence of any physical limitation or restriction that might restrict Lumoral use
- Unwilling to participate in the study
- Pregnancy or lactation
- Active smoking
- Medicated diabetes mellitus (DM)
- Any systemic disease (e.g., wound healing dysfunctions) that could alter the progression of peri-implantitis
- Use of antibiotics and doxycycline, chlorhexidine, and bisphosphonates, within 4 weeks week prior to study participation
- Peri-implant and periodontal treatment within 3 months prior to study participation
- Removable major prosthesis or major orthodontic appliance
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Anti-infective photodynamic therapy for plaque-induced oral conditions
Standard oral hygiene instructions for electric toothbrushing, interdental brush, and dental floss use
non-surgical anti-infective treatment by scaling and root planing
surgical anti-infective peri-implantitis treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06017817